VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
NBTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
NBTXNanobiotix S.A.
$25.75$1.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNBTXQuarterly Financials

Nanobiotix S.A. (NBTX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Nanobiotix S.A. (NBTX) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

NBTX Income Statement

Quarterly statement

NBTX Income Statement

Nanobiotix S.A. (NBTX) annual income statement — 15-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q2'19Q4'18Q2'18Q4'17Q2'17Q4'16
Sales/Revenue3.69M3M26.64M-16.48M9.29M32.91M3.29M3.45M1.33M1.33M1.32M877K1.45M718K1.82M1.42M2.06M1.84M1.88M2.39M
Revenue Growth %-86.14%118.24%186.77%-150.07%182.08%854.89%147.78%159.56%0.76%51.43%-8.91%22.14%-20.57%-49.4%-11.5%-22.87%9.45%-22.89%-38%1.26%
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit03M26.64M-16.48M9.29M32.91M3.29M3.45M1.33M1.33M1.32M877K1.45M718K1.82M1.42M2.06M1.84M1.88M2.39M
Gross Margin %-100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %-100%118.24%186.77%-150.07%182.08%854.89%147.78%159.56%0.76%51.43%-8.91%22.14%-20.57%-49.4%-11.5%-22.87%9.45%-22.89%-38%1.26%
Operating Expenses22.99M14.63M25.83M28.26M32.94M34.32M28.66M24.27M27.21M24.13M31.1M18.92M19.83M27.03M22.29M18.51M15.04M15.3M13.69M14.17M
OpEx % of Revenue622.73%486.89%96.97%-171.5%354.62%104.28%870.42%704.15%2047.1%1816.94%2357.62%2157.47%1369.61%3764.62%1222.71%1304.37%729.95%831.63%727.27%593.76%
Selling, General & Admin10.67M8.93M11.29M9.69M10.82M11.19M10.86M8.22M9.64M9.26M10.18M7.86M6.75M10M8.91M6.45M6.2M4.81M6.45M5.46M
SG&A % of Revenue288.88%297.1%42.4%-58.83%116.47%33.98%329.91%238.5%725.06%697.14%771.49%895.78%466.51%1392.62%488.75%454.76%300.97%261.17%342.68%228.9%
Research & Development11.82M8.59M14.53M18.55M21.99M20.59M17.8M16.03M16.61M14.87M15.51M11.25M13.08M17.03M13.38M12.06M8.84M10.49M7.24M8.71M
R&D % of Revenue320.26%285.72%54.54%-112.59%236.7%62.56%540.69%464.98%1249.66%1119.88%1175.59%1283.12%903.11%2372.01%733.96%849.68%428.98%570.4%384.59%364.86%
Other Operating Expenses501.66K-1000K7K13K135K1000K-6K23K962K-1K1000K-188K000-1K01K00
Operating Income-20.1M-11.63M808K-44.74M-23.65M-1.41M-25.37M-20.82M-25.88M-22.8M-29.78M-18.04M-18.38M-26.31M-20.47M-17.09M-12.98M-13.46M-11.81M-11.78M
Operating Margin %-544.36%-386.89%3.03%271.5%-254.62%-4.28%-770.42%-604.15%-1947.1%-1716.94%-2257.62%-2057.47%-1269.61%-3664.62%-1122.71%-1204.37%-629.95%-731.63%-627.27%-493.76%
Operating Income Growth %-2587.37%74.01%103.42%-3075.3%6.77%93.23%1.96%8.67%13.1%-26.36%-61.98%31.42%10.18%-53.96%-57.72%-26.96%-9.92%-14.26%-17.2%-27.1%
EBITDA-19.3M-10.41M1.08M-44.44M-22.87M-637K-24.63M-20.07M-25.13M-22.04M-28.98M-17.2M-17.48M-25.19M-19.62M-16.86M-12.68M-13.16M-11.65M-11.55M
EBITDA Margin %-522.73%-346.32%4.07%269.65%-246.16%-1.94%-747.92%-582.27%-1890.97%-1659.79%-2196.89%-1960.78%-1207.04%-3508.91%-1076.08%-1187.88%-615.63%-715.23%-619.18%-484.15%
EBITDA Growth %-1880.38%76.58%104.74%-6875.67%7.16%96.83%2%8.94%13.27%-28.18%-65.79%31.75%10.9%-49.47%-54.68%-28.09%-8.82%-13.91%-18.68%-28.75%
D&A (Non-Cash Add-back)798.61K1.22M276K305K786K772K741K754K746K759K801K848K906K1.12M850K234K295K301.78K152.22K229.18K
EBIT-20.1M-14.38M815K-44.73M-23.52M1.14M-25.38M-20.8M-24.92M-22.8M-24.36M-18.23M-18.38M-26.31M-20.47M-17.09M-12.98M-13.46M-11.81M-11.78M
Net Interest Income-14.06M-5.76M-3.65M00-3.4M-3.37M-2.86M1.36M1.22M1.56M1.03M-1.19M458.5K-712.7K00000
Interest Income686.11K985K00000250K1.36M1.22M1.56M1.03M0458.5K20.87K640K173K36.95K38.05K28.58K
Interest Expense14.75M6.75M3.65M003.4M3.37M3.11M00001.19M0733.57K00000
Other Income/Expense-16.56M-6.96M-6.18M-1.56M1.92M-10.07M-2.73M-9.86M-474K6.22M-640K5.04M-2.2M-680K-3.45M-640K362K-492.39K-383.61K70.42K
Pretax Income-36.66M-18.58M-5.38M-46.3M-21.73M-11.48M-28.1M-30.68M-26.35M-16.58M-30.42M-13M-20.58M-26.99M-23.92M-17.73M-12.62M-13.95M-12.19M-11.71M
Pretax Margin %-993%-618.34%-20.19%280.98%-233.91%-34.89%-853.2%-890.05%-1982.77%-1248.49%-2306.14%-1482.44%-1421.27%-3759.33%-1312.12%-1249.47%-612.38%-758.39%-647.65%-490.8%
Income Tax-1.91M-3K6K-43K144K117K3K4K6K3K2K10K1K3K0002121969
Effective Tax Rate %5.22%0.02%-0.11%0.09%-0.66%-1.02%-0.01%-0.01%-0.02%-0.02%-0.01%-0.08%-0%-0.01%0%0%0%-0%-0%-0.01%
Net Income-34.75M-18.58M-5.38M-46.26M-21.87M-11.6M-28.1M-30.68M-26.36M-16.58M-30.42M-13.01M-20.58M-27M-23.92M-17.73M-12.62M-13.95M-12.19M-11.71M
Net Margin %-941.2%-618.24%-20.21%280.72%-235.46%-35.25%-853.29%-890.17%-1983.22%-1248.72%-2306.29%-1483.58%-1421.2%-3759.75%-1312.12%-1249.47%-612.38%-758.39%-647.65%-490.85%
Net Income Growth %-545.54%59.84%75.39%-298.76%22.16%62.19%-6.61%-85.03%13.36%-27.45%-47.82%51.8%13.97%-52.26%-89.62%-27.07%-3.49%-19.14%-19.87%-26.89%
Net Income (Continuing)-34.75M-18.58M-5.38M-46.26M-21.87M-11.6M-28.1M-30.68M-26.36M-16.58M-30.42M-13.01M-20.58M-27M-23.92M-17.73M-12.62M-13.95M-12.19M-11.71M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.71-0.39-0.11-0.98-0.46-0.31-0.80-0.88-0.76-0.48-0.88-0.47-0.91-1.21-1.15-0.90-0.64-0.74-0.76-0.76
EPS Growth %-545.45%60.2%76.09%-216.13%42.5%64.77%-5.26%-83.33%13.64%-2.13%3.3%61.16%20.87%-34.44%-79.69%-21.62%15.79%2.63%-11.76%-8.57%
EPS (Basic)-0.71-0.39-0.11-0.98-0.46-0.30-0.80-0.88-0.76-0.48-0.88-0.47-0.91-1.21-1.15-0.92-0.64-0.74-0.76-0.76
Diluted Shares Outstanding48.88M47.82M47.42M47.27M47.12M38.82M35.04M34.85M34.84M34.81M34.62M27.85M22.61M22.38M20.84M19.63M19.63M18.94M16.04M15.6M
Basic Shares Outstanding48.88M47.82M47.42M47.27M47.12M37.99M35.04M34.85M34.84M34.81M34.62M27.85M22.61M22.38M20.84M19.48M19.63M18.83M16.04M15.6M
Dividend Payout Ratio--------------------